top banner image  

topleft corner image     top right corner image
 


bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Intv, 2008; 1:44-53, doi:10.1016/j.jcin.2007.11.003
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC Interventions
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, A. S.H.
Right arrow Articles by Banning, A. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cheng, A. S.H.
Right arrow Articles by Banning, A. P.

Percutaneous Treatment of Chronic Total Coronary Occlusions Improves Regional Hyperemic Myocardial Blood Flow and Contractility

Insights From Quantitative Cardiovascular Magnetic Resonance Imaging

Adrian S.H. Cheng, MBBS, MRCP*,1, Joseph B. Selvanayagam, FRACP, DPhil*,1, Michael Jerosch-Herold, PhD{dagger}, William J. van Gaal, MD{ddagger}, Theodoros D. Karamitsos, MD*,1, Stefan Neubauer, MD, FRCP*, Adrian P. Banning, MD, FRCP, FESC{ddagger},*

* University of Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, United Kingdom
{dagger} Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon
{ddagger} Department of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom.


Figure 1
View larger version (47K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Changes in MBF in Segments Subtended by a Stenosis and Remote Segments in the 3 Patient Groups

Each myocardial segment is represented by a circle at each time point, with larger circles denoting greater transmural extent of infarction (TEI). Mean ± standard error of the mean are displayed for each time point. Hyperemic myocardial blood flow, measured in ml/min/g, in territories subtended by a chronic total occlusion (CTO) (stenosed segments) decreased significantly with increasing TEI. At baseline, stenosed segments had significantly worse hyperemic myocardial blood flow (MBF) in all patient groups. In both intervention groups, hyperemic MBF was greater in treated segments, relative to baseline, at both 24 h (24h) and 6 months (6m) after percutaneous coronary intervention (PCI), such that the differences in hyperemic MBF between treated segments and remote segments were no longer significant. There was no change in hyperemic MBF in untreated CTO segments or remote segments. Untreated CTO segments had lower hyperemic MBF than treated CTO segments at 6-month follow-up. *p < 0.01 for comparison with baseline; {dagger}p < 0.01 for comparison between stenosed and remote segments at the same time point; {ddagger}p < 0.01 for comparison with CTO PCI group at the same time point. MRI = magnetic resonance imaging.

 

Figure 2
View larger version (40K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Signal Intensity-Time Curves and Stress Perfusion Images Demonstrating Changes in Hyperemic MBF After CTO PCI

Shown is a patient with CTO in the middle portion of the right coronary artery. Baseline, hyperemic MBF is reduced in the midventricular inferoseptal segment, subtended by the CTO, compared with a remote segment in the same slice (top left). Six months after PCI, hyperemic MBF in the revascularized inferoseptal segment has normalized (bottom left). Representative MRI images on the right panels are peak stress midventricular slices at corresponding imaging time points, displaying perfusion deficits in the inferoseptal and inferior segments at baseline (top, borders of the inferoseptal segment delineated by white arrows), which are no longer present 6 months after PCI (bottom). Remote anteroseptal segments are indicated by the black arrow. a.u. = arbitrary units; SI = signal intensity; other abbreviations as in Figure 1.

 

Figure 3
View larger version (24K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Signal Intensity-Time Curves and Stress Perfusion Images Demonstrating No Change in Hyperemic MBF in a Medically Managed Patient With a CTO

A patient with CTO of the middle portion of the right coronary artery. At baseline, hyperemic MBF, measured in ml/min/g, is greatly reduced in this midventricular inferior segment, subtended by the CTO, compared with a remote segment in the same slice (top left). At 6-month follow-up, hyperemic myocardial blood flow in the CTO segment remains unchanged and greatly reduced (bottom left). Magnetic resonance imaging on the right panels are midventricular slices taken at peak stress at the corresponding imaging time points, displaying perfusion deficits in the inferoseptal and inferior segments at baseline (top), which remain at 6-month follow-up (bottom). The borders of the inferoseptal segment are delineated by white arrows; the remote anterior segment is indicated by the black arrow. Abbreviations as in Figures 1 and 2.

 

Figure 4
View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Changes in Wall Thickening in Segments Subtended by a Stenosis and Remote Segments in the 3 Patient Groups

Each myocardial segment is represented by a circle at each time point, with larger circles denoting greater TEI. Mean ± standard error of the mean are displayed for each time point. Wall thickening in territories subtended by a CTO decreased significantly with increasing TEI. At baseline, CTO segments had worse contractility than remote segments. After successful CTO PCI, wall thickening in treated segments improved, such that, after simultaneous adjustment of wall thickening by TEI, the differences between treated segments and remote segments were no longer significant at 24 and 6 months after PCI. Improvement in contractility was less likely in segments with greater TEI before PCI. In patients scheduled for non-CTO PCI, wall thickening improved only at 6 months, relative to baseline. There was no change in wall thickening in untreated CTO segments or remote segments. Untreated CTO segments had significantly worse wall thickening than treated CTO segments at 6-month follow-up. *p < 0.01 for comparison with baseline; {dagger}p < 0.01 for comparison between stenosed and remote segments at the same time point; {ddagger}p < 0.05 for comparison with CTO PCI group at the same time point. Abbreviations as in Figure 1.

 




 
   
 
home link current link search link archive link topics link cardiology careers link